Optimal production and purification of n.c.a.143Pr as a promising palliative agent for the treatment of metastatic bone pain
Crossref DOI link: https://doi.org/10.1038/s41598-024-64321-z
Published Online: 2024-06-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shirvani-Arani, Simindokht
Ranjbar, Hassan
Bahrami-Samani, Ali
Text and Data Mining valid from 2024-06-12
Version of Record valid from 2024-06-12
Article History
Received: 9 March 2024
Accepted: 7 June 2024
First Online: 12 June 2024
Competing interests
: The authors declare no competing interests.